CC

Casdin Capital Portfolio holdings

AUM $1.1B
This Quarter Return
+21.62%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$565M
AUM Growth
+$565M
Cap. Flow
+$85.6M
Cap. Flow %
15.14%
Top 10 Hldgs %
58.05%
Holding
34
New
7
Increased
13
Reduced
–
Closed
3

Top Buys

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$10.7M
2
IBB icon
iShares Biotechnology ETF
IBB
$10.1M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$8.74M
4
ILMN icon
Illumina
ILMN
$6.5M
5
CRSP icon
CRISPR Therapeutics
CRSP
$6.17M

Top Sells

1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.67M
2
GILD icon
Gilead Sciences
GILD
$2.15M
3
OVID icon
Ovid Therapeutics
OVID
$1.58M

Sector Composition

1 Healthcare 89.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$41.5M 7.3% 360,000 – –
FMI
2
DELISTED
Foundation Medicine, Inc.
FMI
$41M 7.2% 520,000 – –
SAGE
3
DELISTED
Sage Therapeutics
SAGE
$40.3M 7.08% 250,000 – –
BPMC
4
DELISTED
Blueprint Medicines
BPMC
$31.9M 5.61% 348,000 – –
ONCE
5
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$30.8M 5.42% 463,000 +160,526 +53% +$10.7M
AGIO icon
6
Agios Pharmaceuticals
AGIO
$2.19B
$29.8M 5.25% 364,776 +69,776 +24% +$5.71M
ALNY icon
7
Alnylam Pharmaceuticals
ALNY
$58.5B
$29.8M 5.24% 250,000 +50,000 +25% +$5.96M
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
$29M 5.1% 600,000 +85,000 +17% +$4.11M
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$27.3M 4.81% 560,000 – –
SGMO icon
10
Sangamo Therapeutics
SGMO
$157M
$26.6M 4.68% 1,400,000 – –
FATE icon
11
Fate Therapeutics
FATE
$120M
$25.4M 4.46% 2,600,000 – –
BLUE
12
DELISTED
bluebird bio
BLUE
$24.8M 4.35% 145,000 – –
CDXS icon
13
Codexis
CDXS
$246M
$22.3M 3.92% 2,025,000 +425,000 +27% +$4.68M
VYGR icon
14
Voyager Therapeutics
VYGR
$186M
$21.3M 3.75% 1,135,000 – –
GNMK
15
DELISTED
GenMark Diagnostics, Inc
GNMK
$20.9M 3.68% 3,850,000 +1,120,000 +41% +$6.09M
ILMN icon
16
Illumina
ILMN
$15.8B
$16.9M 2.97% 71,500 +27,500 +63% +$6.5M
EVH icon
17
Evolent Health
EVH
$1.12B
$15.8M 2.78% 1,110,000 +32,500 +3% +$463K
JNCE
18
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$14.2M 2.5% 635,000 +160,000 +34% +$3.58M
BOLD
19
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.5M 2.38% 450,000 +50,000 +13% +$1.5M
ONC
20
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$11.8M 2.07% 70,000 +52,000 +289% +$8.74M
IBB icon
21
iShares Biotechnology ETF
IBB
$5.6B
$10.1M 1.78% +95,000 New +$10.1M
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
$9.37M 1.65% 177,500 +50,000 +39% +$2.64M
CRSP icon
23
CRISPR Therapeutics
CRSP
$4.71B
$6.17M 1.09% +135,000 New +$6.17M
CTMX icon
24
CytomX Therapeutics
CTMX
$336M
$5.9M 1.04% 207,500 +30,000 +17% +$853K
EDIT icon
25
Editas Medicine
EDIT
$231M
$4.42M 0.78% 133,333 – –
1
2